While this share price fall is not much fun, don't be too worried by posters such as FedEx whose logic changes like the weather. Prior to the relisting where he held shares he was saying things like:
19/3: $400m mkt cap is about right at this stage.
18/3: i think aussie biotechs are the cutting edge and avexa is and will be the leader now in this hiv field..
16/3 i fink 350-400million incl latest placement. Its a working drug. and a necessary drug with a big market and what appears to be little in the way of competition
Market cap of $400m is about a dollar a share.
Then (surprise surprise) he sold a heap as soon as it re-listed. Now all of sudden, FedEx reckons we should all look elsewhere because AVX is looking like droppping to 60C and is going to go nowhere for a couple of years.
Seems a little odd.
Bear in mind that there is always the chance that some posters would like to push the price to their advantage.
AVX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held